Member Info for M_Night

Cheap shares fomo kicking in.

Constant buying since midday.

One hopes it's a sign and perhaps something leaked. hmmm

A correction is due considering the amount of contracts big with pharma companies.

AGL should be 30p+ considering AVCT is £250mil+

Lovely to see the 50pt rate cut from the Fed.

This will means money leaves savings accounts faster and reenters equities to catch the bottom up.

Small caps can perform well over the months and period ahead of reducing rates and inflation back to normal.

POLX POLAREAN IMAGING is a better bet for a growing medical business on AIM for several reasons.

Firstly they have enough cash to last until at least Q1 2026. GDR probably a few months?

Secondly POLX saw only $0.1M revenue in 2023. For 2024 they are projecting $3M. That's 3000% annual growth. For 2025 they are projecting up to $6M. That's up to 6000% revenue growth over 2023. What's GDRs revenue and growth?

Thirdly POLX has fully patended, fully FDA MRI scanning technology and has rolled it out into 21 clinical sites across the US already and this is rising fast if you see the RNS history. Therefore from a technology perspective it's safer.

Next they have major partners and shareholders such as Nukem, Bracco and Philips who have bought a ton of shares. Who are GDRs big insti backers?

Lastly POLX is at 1.6p and once had an all time high of 100p when they had no FDA approval, no revenues but had a singificantly higher marker cap. On the charts there's a gap to fill at 3.5p. Therefore it makes a great recovery play.

None of this is advice and DYOR. GLA etc etc...

han****'s extremely low cost fundamentals are too good to ignore for a major.

and we know the project is surrounded by them, rio tinto. bhp...

Looking forward to the contract updates that are looming. In the meantime adding more at these prices.

Wents I believe an update is nearing and there's a possibility it's Rio Tinto.

I know. My new feeling is telling me an easy 1p+ this year

I just have a feeling I'm going to be kicking myself for not loading up big around here if they drop the big RNS as then I'll probably be struggling to buy at even 0.3p.

If it's someone like Rio Tinto for the JV then 2p.

#POLX

Revenue up several by up to 3,000% this year.

FDA approved.

Major partners.

2 years of cash runway.

Mcap £18m only vs £200m here

Tech validated in 21 active clinical sites

My price target: 20-30p from current 1.6p.

Not advice DYOR.

I suspect one the rate cuts are done and dusted this week from next week we'll see a nice market rally (not that the US needs it considering how strong it is atm) and the money on the sidelines will come back to give us a lift running to xmas.

Then if 1-2 of this conflicts can end 2025 will be a wonderful year for stocks.

So I'm buying in anticipation of this as I think Polarean is an excellent candidate for a recovery stock and a safer bet than lets say mining considering the technology is proven with the FDA and validated across 21 clinical sites.

The revenue surge has been achieved and the recent hires and news bodes well for the future.

Yup, whether the haters like it or not. The assets will be sold.

Before suspension this was going to run over 5p so it will get back to a higher base soon enough considering the asset sales are still happening.

Really oversold at these levels and due a move to 5p even before any news drops

This clearly says Genedrive Https://www.linkedin.com/posts/north-west-genomic-medicine-service-alliance_the-university-of-manchester-has-been-shortlisted-activity-7239977706363236352-dJ9W?utm_source=share&utm_medium=member_ios

New contract tbc via RNS

RNS looks likely for next week

Rather buy here than pay over 4p after a single RNS

Forgot 5p, 20p it is

Looks like a new contract for GDR!